Dow Down 0.06% Nasdaq Up 0.31%

More On APPAD

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Heron Therapeutics, Inc. (APPAD)

-OTC BB
12.30 0.00(0.00%) Jan 22
Prev Close:12.30
Open:12.30
Bid:N/A
Ask:N/A
1y Target Est:25.33
Beta:0.64
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:5.60 - 17.80
Volume:0
Avg Vol (3m):36,523
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-3.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for APPAD at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback